Competitors

Comparison Summary

Discover information and data insights on Apellis Pharmaceuticals Inc's key competitors and market peers.

Key Parameters Apellis Pharmaceuticals IncAmneal Pharmaceuticals IncCytomX Therapeutics IncAclaris Therapeutics Inc
Key Information
Headquarters United States of America United States of America United States of America United States of America
Headquarter City Waltham Bridgewater South San Francisco Wayne
Headquarter State/Province Massachusetts New Jersey California Pennsylvania
No. of Employees 445 5,500 144 60
Entity Type Public Public Public Public
Key Financials
Revenue (US$ m)

-

1,993 (2020)

22.5% (’20 vs ’19)

100 (2020)

74.6% (’20 vs ’19)

6 (2020)

53.2% (’20 vs ’19)
Market Cap (US$ m) - 1,628 319 1,053
Net Income (US$ m)

-

91 (2020)

-125.2% (’20 vs ’19)

-33 (2020)

-67.8% (’20 vs ’19)

-51 (2020)

-68.4% (’20 vs ’19)
EV/Sales - 2.12 0.02 154.78
Profitability Ratios
Gross Margin - 33.27 (2020) - 20.81 (2020)
Net Profit Margin - 4.57 (2020) -32.77 (2020) -787.03 (2020)
Operating Margin #### #### #### ####
PBT Margin #### #### #### ####
Profit Markup #### #### #### ####
Return on Assets #### #### #### ####
Return on Capital Employed #### #### #### ####
Return on Equity #### #### #### ####
Return on Fixed Assets (ROFA) #### #### #### ####
Return on Working Capital (ROWC) #### #### #### ####
Growth Ratios
EBITDA Growth - 105.84% (2020) - -
EPS Growth - - - -
Net Income Growth #### #### #### ####
Operating Income Growth #### #### #### ####
Sales Growth #### #### #### ####
Working Capital Growth #### #### #### ####
Equity Ratios
Book Value per Share - 1.01% (2020) 1.03% (2020) 0.83% (2020)
Cash Value per Share - 1.14% (2020) 3.98% (2020) 0.49% (2020)
Dividend cover #### #### #### ####
Dividend per share #### #### #### ####
EPS #### #### #### ####
Cost Ratios
Administration costs - 16.93% (2020) 35.9% (2020) 316.72% (2020)
Overhead costs - 95.42% (2020) 148.43% (2020) 885.44% (2020)
Liquidity Ratios
Cash Ratio - 0.5% (2020) 3.13% (2020) 3.64% (2020)
Current Ratio - 2.29% (2020) 3.21% (2020) 3.87% (2020)
Quick Ratio #### #### #### ####
Leverage Ratios
Debt to Capital Ratio - 0.9% (2020) - 0.22% (2020)
Debt to Equity Ratio - 9.51% (2020) - 0.28% (2020)
Net Debt to Equity #### #### #### ####
Efficiency Ratios
Asset Turnover - 0.52% (2020) 0.29% (2020) 0.08% (2020)
Capex to sales - 3.32% (2020) 2.3% (2020) 6.99% (2020)
Capital Employed Turnover #### #### #### ####
Current Asset Turnover #### #### #### ####
Fixed Asset Turnover #### #### #### ####
Inventory Turnover #### #### #### ####
Net income per Employee #### #### #### ####
R&D to Sales #### #### #### ####
Revenue per Employee #### #### #### ####
Working Capital Turnover #### #### #### ####
Company Filings
Latest Sentiment Score (Full Document) - 0.27 (2020) 0.3 (2020) 0.26 (2020)
Latest Sentiment Score (Management) - 0.79 (2020) 0.74 (2020) 0.44 (2020)
Deals
Total Deal Volume - - - -
Total Deal Value (US$ m) - - - -
Influencers (Last 30 Days)
Influencers - 93 7 -
Tweets - 149 9 -
Retweets - 2,299 2 -
Job Analytics (Last 30 Days)
Active Jobs - 178 - 12
Posted - 77 - -
Closed - 54 - -
Patents (2020)
Filings - 2 (2020) 67 (2020) -
Growth Filings - -66.67 (2020) 45.65 (2020) -
Grant - 1 (2020) 24 (2020) -